Last month, I called for a Welsh Government statement on multiparametric—or mp—MRI scans for NHS patients for suspected prostate cancer. Subsequently, you wrote to a patient to say that Betsi Cadwaladr university health board does provide mpMRI scans in line with the current NICE guidelines for prostate cancer. The guidelines state that multiparametric MRI should be considered

'for men with a negative transrectal ultrasound 10–12 core biopsy to determine whether another biopsy is needed.'

One of those men you were writing to was one of many men who have contacted me in north Wales who were not offered an mpMRI scan following a negative biopsy, unless they paid around £1,000 to have it carried out at a private hospital. Given that Wrexham Maelor is the only centre in Wales that participated in the England and Wales PROMIS—prostate MRI imaging study—which found that whereas the painful transrectal ultrasound-guided biopsy offered by Betsi Cadwaladr is only 47 per cent accurate, the mpMRI scan is over 90 per cent accurate, how are you ensuring that men in Wales participate in or take advantage of the £75 million research project launched by the UK Prime Minister, which will recruit 40,000 men into trials for better diagnosis and treatments for the disease using mpMRI scans?